Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-15

FDA Approved: EFAVIRENZ — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved an original ANDA for efavirenz (EFAVIRENZ) from Aurobindo Pharma Limited, enabling the marketing of the generic antiretroviral.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)

Snippet

ORIG AP for EFAVIRENZ (EFAVIRENZ)